Marcaine (bupivacaine HCl) injection, USP, 0.5%, Preservative-Free, 30 mL (150 mg) Single-dose Vial, Rx only, Hospira, Inc., Lake Forest, IL 60045 NDC 0409-1560-29
Published October 8, 2014 · Recall initiated: June 17, 2014
Summary
FDA records drug Class I recall D-0002-2015, published October 8, 2014 and initiated June 17, 2014. Recalling firm: Hospira Inc.; Status: Terminated; Reported quantity: 40,730 vials; Lot: Lot # 33-545-DD, Exp. 09/15. Class I means a reasonable probability of serious adverse health consequences or death.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Presence of Particulate Matter: Confirmed customer complaint of discolored solution with visible metal particles embedded in the glass vial and visible in the solution.
What to do
Voluntary: Firm initiated · Press Release
Get an email if MARCAINE has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- MARCAINE
- Manufacturer
- Hospira Inc.
- Distributor
- Nationwide
- Lot
- Lot # 33-545-DD, Exp. 09/15
- Risk classification
- Class I
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAMarcaine 0.25% (bupivacaine HCl) injection, USP, 125 mg/50 mL (2.5 mg/mL), 50 mL Multiple-Dose Vial, Rx only,October 19, 2016
- FDACUBICIN (daptomycin for injection), 500 mg single-use vial, Rx only, Manufactured for: Cubist Pharmaceuticals,October 8, 2014
- FDAAll sterile drugs compounded between 2/21/14 and 2/24/14.October 8, 2014
- FDABrilliance CT System 6/10/16/16P/40 configuration. No packaging, sold as single unit. Computed tomographyOctober 1, 2014
- FDAMarcaine (bupivacaine HCl) injection, USP, 0.25%, Preservative-Free, 10 mL (25 mg) Single-dose Vial, Rx only,June 11, 2014
- FDAMarcaine (bupivacaine HCl) injection, USP, 0.25%, 30 mL single-dose vials-preservative free, packaged inMarch 26, 2014
Questions about this recall
Was Marcaine (bupivacaine HCl) injection, USP, 0.5%, Preservative-Free, 30 mL (150 mg) Single-dose Vial, Rx only, Hospira, Inc., Lake Forest, IL 60045 NDC 0409-1560-29 recalled?
Yes. FDA published recall D-0002-2015 on October 8, 2014. Reported hazard: Presence of Particulate Matter: Confirmed customer complaint of discolored solution with visible metal particles embedded in the glass vial and visible in the solution.
What should I do if I have this product?
Voluntary: Firm initiated · Press Release
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: MARCAINE.